Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Diagnosis and management of asymptomatic MEN 2 gene carriers].

Nihon rinsho. Japanese journal of clinical medicine - 1 May 2004

Okamoto Takahiro

Abstract excerpt

RET genetic testing affords valid clinical strategies in the diagnosis and management of MEN 2. For at risk family members, the test provides accurate diagnosis of gene carriers and best chance of cure of medullary thyroid carcinoma by prophylactic total thyroidectomy. The test results, however, may have medical, psychological, ethical, and social effects on the individuals as well as their families, it is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Carrier Screening
Share to Informed Consent
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogene Proteins

Share to Practice Guidelines as Topic

Share to Proto-Oncogene Proteins c-ret

Share to Receptor Protein-Tyrosine Kinases

Share to Thyroidectomy

Source

Identifiers

PMID: 15148818

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Diagnosis and management of asymptomatic MEN 2 gene carriers].PMID 15148818Read ↗

5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision MedicineSemantic proximity Read ↗

From genes to decisions: evolving views of genotype-based management in MEN 2.Semantic proximity Read ↗

Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report.Semantic proximity Read ↗

[What management for the asymptomatic men carriers of BRCA1 or 2 mutation? Results of a survey in the French oncogenetic centers].Semantic proximity Read ↗

[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].Semantic proximity Read ↗

[Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden].Semantic proximity Read ↗

Accelerated MEN2A in homozygous RET carriers in the context of consanguinity.Semantic proximity Read ↗

Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene.Semantic proximity Read ↗

[One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].Semantic proximity Read ↗

MEN 2A family--prophylactic thyroidectomy for asymptomatic siblings with positive 634 codon mutation.Semantic proximity Read ↗

[The direct gene test in familial medullary thyroid gland carcinoma and in MEN syndromes. Detection of mutations in the ret proto-oncogene saves screening studies].Semantic proximity Read ↗

Prophylactic thyroidectomy in MEN 2A syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.